Risperidone

Overview

Risperidone is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and irritability associated with autistic disorder. It works by antagonizing dopamine D2 receptors and serotonin type 2A (5-HT2A) receptors in the brain.

API suppliers (41)

Suppliers of Risperidone backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV1 active DMF
• INKE SASpain1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• INKE SASpain1 active DMF
• TAPI NL BV1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• TAPI NL BV1 active DMF
• INKE SASpain1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• INTERQUIM SA1 active DMF
• Cipla USA, Inc.USA1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• INTERQUIM SA1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Torrent PharmaceuticalsIndia1 active DMF
• Cipla USA, Inc.USA1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF

Showing 25 of 41 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (146 approved US products), the latest listed US patent on Risperidone expires 17 Mar 2042 and exclusivity 11 May 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas